These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 16305288

  • 1. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overview.
    Bailie GR, Massry SG, National Kidney Foundation.
    Pharmacotherapy; 2005 Dec; 25(12):1687-707. PubMed ID: 16305288
    [Abstract] [Full Text] [Related]

  • 2. [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
    Sakaguchi T, Akizawa T.
    Clin Calcium; 2004 Sep; 14(9):9-14. PubMed ID: 15577103
    [Abstract] [Full Text] [Related]

  • 3. [Pathogenesis of secondary hyperparathyroidism and renal bone disease].
    Ito H, Kinugasa E.
    Clin Calcium; 2004 May; 14(5):720-5. PubMed ID: 15577032
    [Abstract] [Full Text] [Related]

  • 4. Difficulties in achieving the K/DOQI practice guidelines for bone and mineral metabolism.
    González EA, Al-Aly Z, Martin KJ.
    Semin Dial; 2005 May; 18(3):171-4. PubMed ID: 15934956
    [Abstract] [Full Text] [Related]

  • 5. Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.
    Monge M, Shahapuni I, Oprisiu R, El Esper N, Morinière P, Massy Z, Choukroun G, Fournier A.
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):326-36. PubMed ID: 16932454
    [Abstract] [Full Text] [Related]

  • 6. [Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].
    Orita H, Akizawa T.
    Clin Calcium; 2004 May; 14(5):693-7. PubMed ID: 15577029
    [Abstract] [Full Text] [Related]

  • 7. Mineral metabolism disturbances in patients with chronic kidney disease.
    Kestenbaum B, Belozeroff V.
    Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
    [Abstract] [Full Text] [Related]

  • 8. Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified.
    Ix JH, Quarles LD, Chertow GM.
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):337-9. PubMed ID: 16932455
    [Abstract] [Full Text] [Related]

  • 9. [Contributions of the software La Clé Concerto in the implementation of the NKF-K/DOQI (National Kidney Foundation-Kidney/Dialysis Outcomes Quality Initiative) recommendations for the control of mineral and bone metabolism disorders in the patient with chronic renal failure].
    Ureña P.
    Nephrol Ther; 2008 Sep; 4 Spec No 1():9-14, 20-35. PubMed ID: 19031633
    [No Abstract] [Full Text] [Related]

  • 10. Chronic kidney disease-related mineral and bone disorders.
    Argilés A, Vanholder R.
    Nephron Clin Pract; 2009 Sep; 112(3):c128-36. PubMed ID: 19390213
    [Abstract] [Full Text] [Related]

  • 11. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease.
    Raggi P, Kleerekoper M.
    Clin J Am Soc Nephrol; 2008 May; 3(3):836-43. PubMed ID: 18322050
    [Abstract] [Full Text] [Related]

  • 12. [Relationship between sevelamer HCl and vascular calcification].
    Uemura K, Kakuta T, Saito A.
    Clin Calcium; 2007 Mar; 17(3):392-8. PubMed ID: 17339744
    [Abstract] [Full Text] [Related]

  • 13. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
    Williams ME.
    Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
    [Abstract] [Full Text] [Related]

  • 14. [Parathyroid and bone. Mineral and bone disorder and parathyroid function in chronic kidney disease].
    Yano S.
    Clin Calcium; 2007 Dec; 17(12):1870-8. PubMed ID: 18057663
    [Abstract] [Full Text] [Related]

  • 15. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
    Inaguma D, Tatematsu M.
    Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications.
    Uribarri J, National Kidney Foundation.
    Semin Dial; 2004 Apr; 17(5):349-50. PubMed ID: 15461740
    [Abstract] [Full Text] [Related]

  • 20. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R.
    J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.